Talphera, Inc. Common Stock
$1.17
Market Cap
$61.77M
Shares Outstanding
51.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Feb 11, 2011
Round Lot
100
Locale
US
Day Open
$1.21
Day High
$1.21
Day Low
$1.16
Volume
111.0K
VWAP
$1.18
Prev Close
$1.19
Transactions
--
Acc. Volume
--
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Talphera, Inc. Common Stock (TLPH) closed the 2026-09-17 session at $1.17, down 1.68% versus the previous close (-0.02). The stock opened at $1.21 and traded between $1.16 and $1.21 during that session. Session trading volume was 111K shares. The volume-weighted average price (VWAP) is $1.18.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.
Talphera, Inc. Common Stock has a market capitalization of $61.8 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. TLPH is listed on the XNAS exchange. The company employs approximately 12 people. Talphera, Inc. Common Stock is headquartered in SAN MATEO, CA. The recorded listing date is 2011-02-11.
On this page you can find market TLPH stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.